1. Home
  2. HOV vs ARDX Comparison

HOV vs ARDX Comparison

Compare HOV & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOV
  • ARDX
  • Stock Information
  • Founded
  • HOV 1959
  • ARDX 2007
  • Country
  • HOV United States
  • ARDX United States
  • Employees
  • HOV N/A
  • ARDX N/A
  • Industry
  • HOV Homebuilding
  • ARDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HOV Consumer Discretionary
  • ARDX Health Care
  • Exchange
  • HOV Nasdaq
  • ARDX Nasdaq
  • Market Cap
  • HOV 843.6M
  • ARDX 885.2M
  • IPO Year
  • HOV N/A
  • ARDX 2014
  • Fundamental
  • Price
  • HOV $95.60
  • ARDX $3.56
  • Analyst Decision
  • HOV Sell
  • ARDX Strong Buy
  • Analyst Count
  • HOV 2
  • ARDX 9
  • Target Price
  • HOV $120.00
  • ARDX $10.17
  • AVG Volume (30 Days)
  • HOV 137.7K
  • ARDX 4.5M
  • Earning Date
  • HOV 05-20-2025
  • ARDX 07-31-2025
  • Dividend Yield
  • HOV N/A
  • ARDX N/A
  • EPS Growth
  • HOV N/A
  • ARDX N/A
  • EPS
  • HOV 28.18
  • ARDX N/A
  • Revenue
  • HOV $3,062,436,000.00
  • ARDX $361,706,000.00
  • Revenue This Year
  • HOV $0.00
  • ARDX $12.01
  • Revenue Next Year
  • HOV $2.50
  • ARDX $34.66
  • P/E Ratio
  • HOV $3.25
  • ARDX N/A
  • Revenue Growth
  • HOV 7.85
  • ARDX 127.33
  • 52 Week Low
  • HOV $81.15
  • ARDX $3.21
  • 52 Week High
  • HOV $240.34
  • ARDX $8.06
  • Technical
  • Relative Strength Index (RSI)
  • HOV 49.04
  • ARDX 40.62
  • Support Level
  • HOV $90.84
  • ARDX $3.63
  • Resistance Level
  • HOV $99.53
  • ARDX $3.72
  • Average True Range (ATR)
  • HOV 5.77
  • ARDX 0.19
  • MACD
  • HOV 0.02
  • ARDX 0.01
  • Stochastic Oscillator
  • HOV 46.18
  • ARDX 4.65

About HOV Hovnanian Enterprises Inc.

Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations . The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments; Northeast which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia and West Virginia; Southeast which includes Florida, Georgia and South Carolina; and West which includes Arizona, California and Texas. The firm generates maximum revenue from West Segment.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: